In Vivo is the premiere resource for life sciences business strategy, covering the biopharma, medtech, and diagnostics industries in one authoritative package. With a unique understanding of the forces shaping global healthcare, In Vivo delivers the “so what” underpinning industry events, so you can make proactive, rather than reactive business decisions, broker deals with confidence, and identify opportunities your competitors might miss. In Vivo brings you insider interviews with top industry executives, and thought provoking features that help you anticipate future industry trends and keep abreast on the latest in dealmaking, marketing, R&D, regulatory and finance strategies. If you are a senior business strategist or a top industry executive needing to make sense of the rapidly changing healthcare environment – you need In Vivo.